aromasil has been researched along with Dermatitis, Radiation-Induced in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachelot, T; Racadot, S; Visy, A | 1 |
| Charalampous, P; Diamandi, M; Gkogkou, P; Ioannidis, G; Ioannou, R | 1 |
| Avenel-Audran, M; Cellier, P; Georgin-Mège, M; Le Corre, Y; Marchand, A; Martin, L | 1 |
3 other study(ies) available for aromasil and Dermatitis, Radiation-Induced
| Article | Year |
|---|---|
Radiation recall syndrome in a patient with breast cancer, after introduction of everolimus.
Topics: Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Estrogens; Everolimus; Female; Humans; Lymphatic Irradiation; Lymphocele; Mastectomy; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Radiodermatitis; Radiotherapy, Intensity-Modulated; TOR Serine-Threonine Kinases | 2019 |
Radiation-recall dermatitis with the everolimus/exemestane combination ten years after adjuvant whole-breast radiotherapy.
Topics: Androstadienes; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Everolimus; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasms, Second Primary; Radiodermatitis; Radiotherapy, Adjuvant; Sirolimus | 2014 |
Exemestane-induced radiation recall dermatitis and morbilliform rash.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Arthralgia; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Eruptions; Eosinophilia; Epidermis; Exanthema; Female; Humans; Nitriles; Radiodermatitis; Radiotherapy, Adjuvant; Triazoles; Withholding Treatment | 2016 |